Literature DB >> 27193364

Facial Emotion Processing in Aviremic HIV-infected Adults.

A González-Baeza1, F Carvajal2, C Bayón3, I Pérez-Valero4, M Montes-Ramírez4, J R Arribas4.   

Abstract

The emotional processing in human immunodeficiency virus-seropositive individuals (HIV+) has been scarcely studied. We included HIV+ individuals (n = 107) on antiretroviral therapy (≥2 years) who completed 6 facial processing tasks and neurocognitive testing. We compared HIV+ and healthy adult (HA) participants (n = 40) in overall performance of each facial processing task. Multiple logistic regressions were conducted to explore predictors of poorer accuracy in those measures in which HIV+ individuals performed poorer than HA participants. We separately explored the impact of neurocognitive status, antiretroviral regimen, and hepatitis C virus (HCV) coinfection on the tasks performance. We found similar performance in overall facial emotion discrimination, recognition, and recall between HIV+ and HA participants. The HIV+ group had poorer recognition of particular negative emotions. Lower WAIS-III Vocabulary scores and active HCV predicted poorer accuracy in recognition of particular emotions. Our results suggest that permanent damage of emotion-related brain systems might persist despite long-term effective antiretroviral therapy.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Emotional processing; HIV; Neurocognitive impairment

Mesh:

Substances:

Year:  2016        PMID: 27193364     DOI: 10.1093/arclin/acw023

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  2 in total

1.  Vocal emotion processing deficits in HIV-infected individuals.

Authors:  A González-Baeza; J R Arribas; I Pérez-Valero; S Monge; C Bayón; P Martín; S Rubio; F Carvajal
Journal:  J Neurovirol       Date:  2016-12-09       Impact factor: 2.643

2.  Emotional Processing in Healthy Ageing, Mild Cognitive Impairment, and Alzheimer's Disease.

Authors:  José Cárdenas; María J Blanca; Fernando Carvajal; Sandra Rubio; Carmen Pedraza
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.